We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

544 hedge funds and large institutions have $2.01B invested in iShares US Medical Devices ETF in 2023 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 152 increasing their positions, 224 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more call options, than puts

Call options by funds: $18.6M | Put options by funds: $12.7M

3.75% more ownership

Funds ownership: 35.74%39.49% (+3.8%)

7% less funds holding

Funds holding: 585544 (-41)

8% less capital invested

Capital invested by funds: $2.19B → $2.01B (-$185M)

32% less repeat investments, than reductions

Existing positions increased: 152 | Existing positions reduced: 224

40% less funds holding in top 10

Funds holding in top 10: 159 (-6)

46% less first-time investments, than exits

New positions opened: 43 | Existing positions closed: 80

Holders
544
Holders Change
-41
Holders Change %
-7.01%
% of All Funds
8.63%
Holding in Top 10
9
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-40%
% of All Funds
0.14%
New
43
Increased
152
Reduced
224
Closed
80
Calls
$18.6M
Puts
$12.7M
Net Calls
+$5.93M
Net Calls Change
+$11.6M
Name Holding Trade Value Shares
Change
Change in
Stake
National Bank of Canada
176
National Bank of Canada
Quebec, Canada
$1.25M +$21.1K +397 +2%
IA
177
IFG Advisory
Georgia
$1.24M -$118K -2,212 -8%
PWA
178
Primoris Wealth Advisors
Florida
$1.23M -$13.3K -250 -1%
QIM
179
Quantitative Investment Management
Virginia
$1.23M +$55.7K +1,048 +4%
Creative Planning
180
Creative Planning
Kansas
$1.22M -$673K -12,660 -33%
FFS
181
Founders Financial Securities
Maryland
$1.22M +$75.8K +1,425 +6%
GVAG
182
Great Valley Advisor Group
Delaware
$1.19M +$520K +9,774 +66%
CA
183
Crumly & Associates
Illinois
$1.16M -$294K -5,523 -19%
KWM
184
Kingsview Wealth Management
Oregon
$1.15M +$322K +6,060 +34%
VF
185
Virtu Financial
New York
$1.15M -$126K -2,374 -9%
SMFG
186
Sumitomo Mitsui Financial Group
Japan
$1.13M +$255K +4,799 +26%
BAM
187
Belpointe Asset Management
Nevada
$1.12M -$118K -2,214 -9%
FWM
188
Forza Wealth Management
Florida
$1.1M -$10.6K -200 -0.9%
PIA
189
Panoramic Investment Advisors
Colorado
$1.08M +$1.18M +22,231 New
BKA
190
Brick & Kyle Associates
Pennsylvania
$1.07M
HI
191
Harbour Investments
Wisconsin
$1.07M -$106K -1,996 -8%
PCA
192
Prosperity Capital Advisors
Ohio
$1.06M -$66.5K -1,251 -5%
JPLA
193
Joseph P. Lucia & Associates
New York
$1.06M -$142K -2,672 -11%
NL
194
NWAM LLC
Washington
$1.06M -$29.6K -557 -2%
CL
195
Choreo LLC
Illinois
$1.06M -$129K -2,427 -10%
BFEC
196
Benjamin F. Edwards & Company
Missouri
$1.06M +$62.7K +1,180 +6%
EDRH
197
Edmond de Rothschild Holding
Switzerland
$1.05M +$275K +5,180 +31%
BCI
198
Brinker Capital Investments
Pennsylvania
$1.05M -$63.7K -1,198 -5%
OPS
199
Orion Portfolio Solutions
Nebraska
$1.05M -$63.7K -1,198 -5%
Fidelity Investments
200
Fidelity Investments
Massachusetts
$1.05M -$114K -2,149 -9%

IHI Hedge Fund Activity: Q3 2023 in Review

544 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q3 2023, worth a combined $2.01B — down 8.4% from $2.19B a quarter earlier.

Sellers outnumbered buyers: 80 funds closed out of IHI and 43 opened new positions — a net loss of 37 holders — while 224 trimmed existing stakes and 152 added.

The largest buyer was Bank of America, adding an estimated $50.2M. The largest seller was Morgan Stanley, cutting an estimated $34.4M.

  • 544 institutional investors held iShares US Medical Devices ETF (IHI) as of Q3 2023, down from 585 in Q2 2023.
  • Funds reported $2.01B of iShares US Medical Devices ETF stock for Q3 2023, down 8.4% quarter-over-quarter.
  • 43 funds opened new iShares US Medical Devices ETF positions in Q3 2023 and 80 closed out, a net change of -37 holders.
  • The largest iShares US Medical Devices ETF buyer in Q3 2023 was Bank of America, an estimated $50.2M added.
  • The largest iShares US Medical Devices ETF seller in Q3 2023 was Morgan Stanley, an estimated $34.4M sold.

Based on aggregated 13F filings for Q3 2023.